Home Cart Sign in  
Chemical Structure| 501919-59-1 Chemical Structure| 501919-59-1

Structure of NSC 74859
CAS No.: 501919-59-1

Chemical Structure| 501919-59-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NSC 74859 (S3I-201) displays selectivity as a Stat3 inhibitor, with an IC50 of 86 μM.

Synonyms: S3I-201

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NSC 74859

CAS No. :501919-59-1
Formula : C16H15NO7S
M.W : 365.36
SMILES Code : O=C(O)C1=CC=C(NC(COS(=O)(C2=CC=C(C)C=C2)=O)=O)C=C1O
Synonyms :
S3I-201
MDL No. :MFCD09907564
InChI Key :HWNUSGNZBAISFM-UHFFFAOYSA-N
Pubchem ID :252682

Safety of NSC 74859

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of NSC 74859

JAK-STAT

Isoform Comparison

Biological Activity

Description
NSC 74859 (S3I-201) acts as a selective inhibitor of Stat3, demonstrating an IC50 of 86 μM[1].
Target
  • STAT3

    STAT3, IC50:86 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 cells 50 μM inhibit STAT3 phosphorylation Nat Commun. 2023 Apr 24;14(1):2342.
SW480 100 μM 1 h Inhibit STAT3 dimerization and nuclear translocation, preventing the nuclear-to-cytosolic shift of hMSH3 Gastroenterology. 2015 Mar;148(3):579-89.
A549 100 μM 1 h Inhibit STAT3 dimerization and nuclear translocation, preventing the nuclear-to-cytosolic shift of hMSH3 Gastroenterology. 2015 Mar;148(3):579-89.
mouse peritoneal macrophages 100 μM 48 h To investigate the effect of NSC 74859 on the IL-23-induced expression of IL-17A, IL-17F, and IL-22 in macrophages. The results showed that NSC 74859 significantly reduced the mRNA and protein expression of these cytokines. Protein Cell. 2018 Dec;9(12):1027-1038.
Daoy cells 200 µM 24 h To examine the effect of NSC 74859 on the proliferation of Shh MB cells, results showed that NSC 74859 significantly inhibited the proliferation of Daoy cells. Mol Oncol. 2022 Feb;16(4):1009-1025.
Daoy cells 75 µM 24 h To examine the effect of NSC 74859 in combination with Sant-1 on the proliferation of Shh MB cells, results showed that the combination treatment significantly enhanced the inhibition of cell proliferation. Mol Oncol. 2022 Feb;16(4):1009-1025.
Daoy cells 100 µM 48 h To examine the effect of NSC 74859 on the apoptosis of Daoy cells, results showed that NSC 74859 significantly induced cell apoptosis. Mol Oncol. 2022 Feb;16(4):1009-1025.
TF-1(R140Q) cells 50, 100, 200 µM 7 days NSC74859 did not restore the EPO-induced differentiation of TF-1(R140Q) cells Cell Commun Signal. 2024 Feb 12;22(1):116.
TF-1(R140Q) cells 50, 100, 200 µM 3 days NSC74859 inhibited the cytokine-independent proliferation of TF-1(R140Q) cells in a concentration-dependent manner with IC50 of 276.8 µM Cell Commun Signal. 2024 Feb 12;22(1):116.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Math1-Cre-ER-Ptc flox/flox mouse model Intraperitoneal injection 50 mg/kg Every other day for 2 weeks To examine the effect of NSC 74859 on tumor formation in the Shh MB mouse model, results showed that NSC 74859 significantly inhibited tumor formation. Mol Oncol. 2022 Feb;16(4):1009-1025.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.74mL

0.55mL

0.27mL

13.69mL

2.74mL

1.37mL

27.37mL

5.47mL

2.74mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories